Graphical abstract
graphic file with name fx1.jpg
[41]Open in a new tab
Highlights
* •
Magnetic force direction affects the morphology and proliferation
of MLO-Y4 osteocytes
* •
Magnetic direction affects ECM-integrin-CSK axis-related proteins
in MLO-Y4 cells
* •
Cytoskeleton stabilization influences intracellular Wnt signaling
in MLO-Y4 cells
* •
Thus, magneto-mechanical stimulation affects the function of MLO-Y4
osteocytes
__________________________________________________________________
Cellular physiology; Molecular biology; Developmental biology.
Introduction
In 1936, Kolin[42]^1 first proposed the idea of employing
electromagnetic fields in medical research. He demonstrated that, in
general, biological systems are greatly influenced by the application
of external magnetic fields. Permanent and man-made alternating
magnetic fields of various strengths surround humans in daily life,
including geomagnetic fields, stray fields from electromagnets and
permanent magnets, as well as electromagnetic fields near electric
devices and electric power lines.[43]^2 Magnetic resonance imaging
(MRI) is undoubtedly a major success in the use of man-made
high-magnetic fields in the clinical field. As a non-invasive,
non-ionizing, and non-destructive medical diagnostic technique, MRI is
widely used in clinical and animal research. The three distinct fields
formed during the use of MRI include a static magnetic field (
[MATH: B0 :MATH]
), time-dependent gradient fields, and the radiofrequency transmitter
field (
[MATH: B1 :MATH]
).[44]^3^,[45]^4 High-strength magnets allow for greater
signal-to-noise ratios, resulting in higher resolution or shorter scan
times. The increasing demand for spatial resolution and a high
signal-to-noise ratio drives the development of stronger magnetic field
systems. The 10.5 T whole-body MRI scanner installed at the University
of Minnesota’s Center for Magnetic Resonance Research (CMRR) is the
most powerful whole-body MRI machine available for human use till
date.[46]^5 The past few decades have seen the rapid development of a
wide range of technologies for generating high and ultra-high magnetic
fields.[47]^6^,[48]^7^,[49]^8 The increasing magnetic field strength is
accompanied by an exacerbation of the field inhomogeneity problem, that
is, the magnetic field gradient.[50]^9 The magnetic field gradient
describes the change in external magnetic field strength with respect
to distance (dB/dz). The spatial gradient is the key parameter of the
[MATH: B0 :MATH]
field, which determines the attraction, a translation force exerted on
an object. It is measured in Gauss per centimeter (G/cm) or Tesla per
meter (T/m) and is represented by
[MATH: ∇→B0
:MATH]
, with its magnitude as
[MATH: |∇→B0<
mo stretchy="true">| :MATH]
[51]^10. Magnetic fields have different or even opposite biological
effects at the cellular and whole-organism level. A major issue is that
the magnetic induction intensity and the magnetic signal gradients that
drive cells are too small and are below the significance
threshold.[52]^11^,[53]^12
Hall et al.[54]^13 reported that working ion channels generate weak
magnetic fields of 10^−9–10^−5 T due to ion currents using a
nitrogen-vacancy probe. In fact, various components within cells have
certain magnetic properties. For example, magnetic correlation and
magnetic moment formation are key electronic properties of oxygenated
and deoxygenated hemoglobin. These properties, which arise from the
strongly correlated electrons, affect hemoglobin function.[55]^14 The
response of cells and intracellular structures to magnetic forces in an
applied magnetic field can be elastic, viscous, or viscoelastic.[56]^15
Magnetic forces influence orientation and sample movement in gradient
fields.[57]^16
Over the past 20 years, large gradient high-static magnetic fields
(LG-HMFs) have undergone significant advances for ground-based
simulations of weightlessness[58]^17 and cellular magnetism
studies.[59]^18 Qiang et al.[60]^19 collaborated with Japan
Superconductor Technology Inc. to design and manufacture
superconducting magnets (JMTA-16T50MF) that can generate LG-HMFs. The
specifications of the superconducting magnet are similar to those
described by Hirose.[61]^20 If the diamagnetic material droplet is
placed in a vertically oriented magnetic field gradient, the apparent
gravity of the droplet can be attenuated or enhanced to different
extents by the magnetic force. In a mouse safety study investigating
the effect of 3.5–23.0 T static magnetic fields, the increase in spleen
weight was more evident in groups with field intensity of 13.5 T and a
gradient of 117.2 T/m, rather than in those with the highest field
intensity (23.0 T).[62]^21 This observation further suggested that the
magnetic field gradient is a key factor contributing to magnetic
field-induced biological effects. Water and biological materials, such
as DNA, proteins, and lipids are examples of diamagnetic
materials.[63]^7^,[64]^22 The magnetic susceptibility of diamagnetic
materials is represented by a small negative value. For example, for
water at 37°C, the diamagnetic susceptibility χ is ≈ −9.05 × 10^−6 (SI
unit).[65]^23 Most tissue constituents have a volume magnetic
susceptibility that is similar to that of water.[66]^24 When placed in
a gradient magnetic field, the direction of the magnetic force on the
diamagnetic substance points from the stronger field to the weaker
region.[67]^12^,[68]^25 The repulsive diamagnetic force on diamagnetic
materials can counteract and superimpose with gravity in the bore of a
superconducting solenoid and powerful “bitter”
electromagnet.[69]^19^,[70]^25
The magnetic force of a unit volume of material is calculated according
to the equation:
[MATH: F=−χpμ0Bd
Bdz
:MATH]
where B is the magnetic flux density, μ[0] is the magnetic permeability
of vacuum (=4π × 10^−7 H/m), χ represents volume susceptibility, and z
is the vertical site coordinate.[71]^26^,[72]^27 The magnetic force is
special as a mechanical stimulus as it is a function of the density of
materials.[73]^28 Since the advent of the LG-HMF, it has been used for
life science research, which has led to novel
findings.[74]^27^,[75]^29^,[76]^30
Osteocytes are the most abundant resident cells in the bone, accounting
for 90–95% of the total cellular component in the adult
skeleton.[77]^31 As such, osteocytes are the master regulators of bone
homeostasis.[78]^31 Furthermore, osteocytes are endocrine cells that
regulate phosphate metabolism in multiple tissues. Most importantly,
osteocytes act as primary mechanosensory cells.[79]^32^,[80]^33 They
are more responsive to mechanical stimulation than osteoblasts and
trigger a greater calcium influx while releasing more prostaglandin
(PGE2) and nitric oxide (NO), in addition to exhibiting more rapid
β-catenin-mediated transcription.[81]^31 Osteocyte mechano-transduction
is a complex but exquisite regulatory process occurring between
different mechanosensory cells, between cells and their environment, as
well as between neighboring cells.[82]^34 The cellular
mechano-transduction process requires designated mechanotransducers to
convert mechanical force into various fundamental biological
signals.[83]^35 In general, the force applied to the cell-matrix
adhesion first causes physical deformation of the ECM, with mechanical
signals then transmitted from the ECM-integrin bond, to adapter
proteins, and finally, to the cytoskeleton.[84]^36 Catch bonds have
been mostly described for ECM-integrin interactions but were recently
identified in adapter protein interactions, such as that between
vinculin and actin.[85]^37 Huang et al. discovered that vinculin forms
a force-dependent catch bond with F-actin through its tail domain, with
lifetimes that depended on the direction of the applied force.[86]^37
The cytoskeleton typically moves mechanical signals from the site of
assembly at the leading edge toward the cell centers.[87]^38 Osteocytes
respond to mechanical stimuli by initiating intracellular signaling and
producing factors that activate both osteoclasts and osteoblasts to
remodel bone.[88]^39 The most researched and best described pathways
induced by mechanical stimulations are those involving NO, ATP, PGEs,
Ca^2+, and Wnt, which are the first factors to be released by
mechanically stressed osteocytes. Blocking one of these signaling
pathways inhibits loading-induced bone anabolism.[89]^40^,[90]^41
Several experimental settings have been developed to study cells under
reduced mechanical cues, including the random positioning
machine,[91]^42 slow-rotating wall vessels, the 3D clinostat, or
antimagnetism levitation.[92]^43 Commercial and custom-made devices
used in studies can load cells with a wide range of mechanical stimuli
such as tension, compression, centrifugation, shear, and
vibration.[93]^44 Different concepts and equipment designs produce
mechanical stimuli of different amplitude and frequency that may lead
to different strain axes and thus exhibit distinct effects on cellular
reflection. Comparisons between studies should thus be made with
caution. Therefore, it is of particular importance to study the effects
of mechanical stimuli of the same type, size, and duration acting on
cells.
When the mechanical state to which the bone is subjected changes, the
internal structure of the bone changes and adapts accordingly while
creating an optimal load-bearing structure. Explaining the cellular and
molecular mechanisms through which this mechanical stimulus leads to
bone reconstruction is the main current research task in the field of
bone cell mechanics. In this study, magneto-mechanical stimuli of the
same size and properties but in opposite directions were used to study
the changes in cell structure and function of osteoblasts in response
to mechanical loading and unloading.
Results
Cells survive in 12 T LG-HMFs
The magnet we used ([94]Figure 1A) provides a high-homogeneous static
magnetic field (SMF) at its center. The magnetic field direction is
vertically upward. MLO-Y4 cell colony numbers decreased under 12 T
upward treatment, while increasing under 12 T downward treatment
([95]Figure 2A). To observe the effects of LG-HMFs with opposite
orientation on the MLO-Y4 relative cell number and viability, we used
the blood count method and CCK-8 assays, respectively. Relative cell
number and viability decreased under 12 T upward treatment, while
increasing under 12 T downward treatment at 24, 48, and 72 h
([96]Figures 2B and 2C). Flow cytometry revealed that 12 T upward
treatment for 24 h significantly promoted cell apoptosis.
Alternatively, 12 T downward treatment inhibited osteocyte apoptosis
([97]Figures 2D and 2E). Western blotting analysis was performed to
determine the changes in the expression of apoptosis-related proteins
Bax and cleaved caspase 3. The 12 T upward treatment significantly
promoted the expression of Bax and cleaved caspase3 in MLO-Y4 cells
([98]Figure 2F), whereas the 12T downward treatment showed a decreasing
trend, but this was not statistically significant ([99]Figure 2F). The
12 T upward magnetic field applied for 24 h significantly altered
osteocyte morphology, and the synapses became elongated. Conversely,
the 12 T downward treatment had no significant effect on osteocyte
morphology ([100]Figure 2G). By counting the cell area and number of
dendrites, we found that they decreased after 12T upward treatment,
whereas no effect was observed after 12T downward treatment
([101]Figure 2H).
Figure 1.
[102]Figure 1
[103]Open in a new tab
The LG-HMFs exposure system
(A) Superconducting magnet (JMTA-16T50MF) and the object stage of cell
culture.
(B) Parameters of the superconducting magnet.
(C) Magnetic field distribution in the magnetic cavity.
(D) B(dB/dz) represents the variation of the magnetic force with
position.
(E) Plot of radial apparent gravity fit at the 12 T upward position.
(F) Plot of radial apparent gravity fit at the 12 T downward position.
(G) Schematic diagram of the magnetic forces and gravity on the cell in
the magnet chamber.
Figure 2.
[104]Figure 2
[105]Open in a new tab
The influence of a different direction of magnetic force on growth of
MLO-Y4 cells
(A) The clonogenic ability of MLO-Y4 cells.
(B) The blood cell count method calculates the number of cells; n = 3.
(C) CCK8 assay for cell viability; n = 3.
(D and E) Flow cytometric analysis of osteocytes to examine cell
apoptosis.
(F) Protein expression levels of Bax and cleaved caspase 3.
(G) Observation of cellular morphology by crystal violet staining.
Scale bar: 100 μm.
(H) Analysis of the cellular area and the number of dendrites in
osteocytes by using Image-Pro Plus software; n = 100.
Data shown as mean ± SD. ∗p < 0.05, ∗∗ <0.01, ∗∗∗ <0.001.
DEG analysis
Control, 12 T upward, and 12 T downward-treated cells were subjected to
RNA sequencing ([106]Figure 9). Compared to the control, 12 T
upward-treated MLO-Y4 cells exhibited 614 DEGs, of which 214 were
upregulated and 400 were downregulated ([107]Figure 3A). Alternatively,
12 T downward-treated MLO-Y4 cells exhibited 94 DEGs, of which 40 were
upregulated and 54 were downregulated ([108]Figure 3B). Furthermore,
there were 565 DEGs in the 12 T upward group compared to the 12 T
downward group. Upregulated and downregulated DEGs are shown in volcano
plots ([109]Figure 3C). The Venn diagram shows 35 common DEGs in the
two treatment groups relative to the control ([110]Figure 3D). These
included Wisp2, Col5a3, Oas2, Plin4, Parp11, Sp100, Uba7, Trim30a,
Stat1, Il4ra, Hist1h1c, Oas3, Gbp7, Cmpk2, Slfn8, Trim30d, Ifi47, Rbm3,
Usp18, Tor3a, Uap1l1, Gm6136, Gm20559, Ccl2, Herc6, Cd80, Cirbp, Cbs,
Ifi207, Rpl9-ps6, Gm9115, Ctso, Tnfaip3, Tlr3, and Gm7666. After
identifying the DEGs, we performed a hierarchical cluster analysis with
the upregulated and downregulated genes illustrated in a heatmap
([111]Figure 3E). Gene counts were log[112]^10 transformed and
normalized as Z score. In [113]Figure 3E, two clusters were clearly
displayed; all control groups were in one cluster and the LG-HMF groups
in another cluster, which indicates high-intragroup consistency and
high-intergroup variability.
Figure 9.
Figure 9
[114]Open in a new tab
Library preparation for transcriptome sequencing.
Figure 3.
[115]Figure 3
[116]Open in a new tab
DEG expression profiles of osteocytes after different direction
magnetic force treatment
(A) Volcano plot of DEGs between 12 T upward and control groups.
(B) Volcano plot of DEGs between 12 T downward and control groups.
(C) Volcano plot of DEGs between 12 T upward and 12 T downward groups.
(D) Venn diagram of DEGs.
(E) Heatmap of cluster analysis of DEGs. Red indicates DEGs with high
expression, and blue indicates DEGs with low expression.
Gene ontology (GO) enrichment analysis of DEGs
We performed GO enrichment analysis on DEGs, with p < 0.05 as the
significance threshold. Genes were enriched in terms in the biological
process (BP), cellular component (CC), and molecular function (MF)
categories. GO enrichment classification maps of DEGs from the 12 T
upward ([117]Figure 4A) and 12 T downward ([118]Figure 4B) treatment
groups were generated. DEGs in the 12 T upward treatment group were
enriched for defense response, regulation of cytokine production, and
mitotic E in the BP category. For CC, the highest number of genes was
enriched for ECM. Enriched MF terms included platelet-derived growth
factor binding, growth factor binding, and receptor regulator activity
([119]Figure 4A). For the 12 T downward treatment group, significant BP
terms included toll-like receptor signaling pathway, defense response
against other organisms, and positive regulation of nitric oxide
synthase. Among CC terms, the ribosomal subunit had the highest number
of enriched genes. Lastly, CCR chemokine receptor binding, sulfur
compound binding, and glycosaminoglycan binding were the significant MF
terms ([120]Figure 4B).
Figure 4.
[121]Figure 4
[122]Open in a new tab
GO enrichment analysis of DEGs
(A) GO enrichment classification map of DEGs of 12 T upward with
control.
(B) GO enrichment classification map of DEGs of 12 T downward with
control.
Effects of LG-HMFs on the ECM-integrin-CSK
We subjected DEGs between the 12 T upward and 12 T downward treatment
groups to Reactome pathway analysis, with p < 0.05 as a significance
threshold. In [123]Figure 7A, significant pathways were plotted using a
bubble diagram and result indicated that DEGs were mainly associated
with ECM proteoglycans, ECM organization, and integrin cell surface
interactions. Further, 12 T upward treatment significantly inhibited
the expression of ECM proteins LAMB1 and integrin β1. In contrast, 12 T
downward treatment significantly promoted the expression of ECM
proteins LAMB1 and integrin β1 ([124]Figures 5A and 5B). Under control
and 12 T downward conditions, MLO-Y4 cells showed star-like shape, and
their actin fibers were evenly distributed across the cell bodies. The
cells are abundant in actin fibers, which branch or rebranch in
different planes of the cell body, forming intercellular connections
with surrounding bone cells. However, under the 12 T upward conditions,
MLO-Y4 cells exhibited a relatively long cell body shape, with a
discontinuous and loose cytoskeleton ([125]Figure 6A). We also examined
the expression of microfilament protein β-actin and microtubulin
protein β-tubulin, observing no significant differences except that
12 T downward treatment could promote β-tubulin expression. However,
12 T upward treatment significantly downregulated the expression of
skeleton-binding protein vinculin, while 12 T downward treatment had
the opposite effect ([126]Figure 6B).
Figure 7.
[127]Figure 7
[128]Open in a new tab
Effect of magnetic force on the Wnt signaling pathway in MLO-Y4 cells
(A) The Reactome enrichment analysis of 12 T upward and 12 T downward;
significant pathways were plotted in the bubble diagram.
(B) Protein interactions network map centered on wisp2.
(C) Subcellular localizations of wisp2.
(D) Protein expression levels of the Wnt signaling pathway (Wnt1, LRP6,
β-catenin, and SOST).
Data shown as mean ± SD. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001; vs. control.
Figure 5.
[129]Figure 5
[130]Open in a new tab
The influence of different direction of magnetic force on ECM and
integrin
(A) Immunoluminescent staining of ECM proteins (LAMB1 and Collagen Ι)
and integrin ligand proteins (integrin β1). Scale bar: 75 μm.
(B) Protein expression levels of LAMB1, Collagen Ι, and integrin β1.
Data shown as mean ± SD. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs.
control.
Figure 6.
[131]Figure 6
[132]Open in a new tab
The influence of different direction of magnetic force on the
cytoskeleton in osteocytes
(A) Immunoluminescent staining of F-actin and β-tubulin. Scale bar:
30 μm.
(B) Protein expression levels of β-actin, β-tubulin, and Vinculin.
Data shown as mean ± SD. ∗p < 0.05, ∗∗p < 0.01.
LG-HMFs regulate the Wnt pathway in MLO-Y4
DEGs between the 12 T upward and 12 T downward treatment groups were
subjected to pathway enrichment analysis, with significant terms
including the Wnt/β-catenin pathway ([133]Figure 7A). Wisp2
(Wnt1-inducible signaling pathway protein 2) was the most significant
DEG between the 12 T upward and 12 T downward groups. We analyzed Wisp2
using the STRING protein interaction database to obtain the protein
networks that interact with Wisp2 ([134]Figure 7B). The GeneCards
database indicated that Wisp2 localized to the nucleus, ECM, and CSK
([135]Figure 7C). The STRING database highlighted the Wnt signaling
pathway as the most relevant to Wisp2. Wnt signaling is
mechanosensitive and acts downstream of mechanical stimuli during
skeletogenesis.[136]^45 Here, 12 T upward treatment significantly
inhibited the expression of Wnt pathway-related proteins, including
Wnt1, β-catenin, and LRP6, in MLO-Y4 cells ([137]Figure 7D).
Sclerosteosis (SOST) has an inhibitory effect on the Wnt pathway.
Furthermore, 12 T upward treatment for 48 h significantly promoted the
protein expression of SOST, while inhibiting that of Wnt pathway
members ([138]Figure 7D). To verify whether the LG-HMF affects Wnt
pathway factor expression in light of its effect on the skeleton, we
pretreated MLO-Y4 cells with a low concentration of paclitaxel (0.5 μM)
for 24 h before placing them under 12 T upward magnetic field
conditions. We discovered that cytoskeleton stabilization in the LG-HMF
stimulated Wnt signaling ([139]Figure 7D). At the same time, colchicine
(0.5 μM) pretreatment at a low concentration significantly inhibited
the effect of 12 T downward treatment on Wnt signaling in MLO-Y4 cells
([140]Figure 7D).
Conditioned medium (CM) from LG-HMF-treated osteocytes promotes osteoclasts
differentiation
Osteocytes are the main regulators of bone homeostasis, exerting their
effects through paracrine signaling to coordinate the differentiation
and function of osteoclasts and osteoblasts.[141]^46 To determine
whether LG-HMFs influence osteocyte function, we examined the effect of
CM on bone differentiation in pre-osteoblast RAW264.7 cells. Osteoclast
differentiation was evaluated based on F-actin rings and TRAP staining.
Compared with those in control CM-treated group, the area of F-actin
rings ([142]Figure 8A) and number of TRAP-positive multinucleated cells
([143]Figures 8B and 8C) were increased after treatment with CM from
12 T upward-treated osteocytes, while they decreased after treatment
with the CM from 12 T downward-treated osteocytes. OPG and NO are
factors released by osteoblasts to inhibit osteoclast differentiation
and activity.[144]^47 The 12 T upward treatment inhibited OPG
(osteoclastogenesis inhibitory factor) and NO synthesis, whereas 12 T
downward treatment promoted it ([145]Figures 8D and 8E).
Figure 8.
[146]Figure 8
[147]Open in a new tab
LG-HMFs affect the function of MLO-Y4 osteocytes
(A) Osteoclast differentiation was evaluated by the F-actin ring
staining.
(B and C) Osteoclast differentiation was evaluated by the TRAP
staining.
(D) Detection of NO secretion in CM.
(E) Protein expression levels of OPG.
Data shown as mean ± SD. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001; vs. control. ^#p < 0.05, ^##p < 0.01, ^###p < 0.001,
^####p < 0.0001; 12 T upward vs. 12 T downward. Scale bar: 200 μm.
Discussion
Magnetic forces generated by magnetic fields act on cellular
components, including the cell membrane, cytoplasm, cytoskeleton,
nucleus, and intracellular motors, thus, triggering cellular signaling
pathways. We have previously shown that simulated microgravity
generated by LG-HMF influences the fate of MC3T3-E1
osteoblasts.[148]^27^,[149]^48 In the current study, we used
LG-HMF-generated magnetic forces with the same magnitude and opposite
direction to investigate the effects of magnetic force loading in
different directions on cell fate and the underlying mechanisms. We
observed that the viability and relative number of osteocytes cultured
under 12 T downward treatment for 24 h were enhanced, while the same
parameters were decreased following 12 T upward treatment. There was no
significant change in cell morphology, cell area, and number of cell
dendrites in the 12 T downward treatment group compared with those in
the geomagnetic group, and apoptosis tended to decrease, which may
account for the increase viability of MLO-Y4 cells. Alternatively, the
12 T upward treatment significantly promoted cell apoptosis, with
changes in osteocyte morphology, dendrites elongation and reduced
dendrites number, which directly led to a decrease in cell number and
viability.
Compared to controls, 12 T upward-treated MLO-Y4 cells exhibited 614
DEGs, while 94 DEGs were obtained for 12 T downward-treated cells. This
suggests that the upward magnetic force may cause more biological
effects. We further performed GO functional enrichment analysis of the
DEGs. GO enrichment results showed that the biological processes that
changed after both 12 T upward and 12 T downward treatment were
associated with the regulation of defense responses, collagen
polymerization, extracellular matrix protein binding, integrin binding,
and ion binding. Interestingly, the biological processes that change in
MLO-Y4 cells after 12 T upward treatment include regulation of
cell-cell adhesion, while the biological processes that change after
12 T downward treatment include nitric oxide synthase biosynthesis
processes. At the same time, DEGs between the 12 T upward and 12 T
downward groups were subjected to analysis based on the Reactome
database. These were associated with ECM proteoglycans, ECM
organization, and integrin cell surface interactions. To further
validate the transcriptome-sequencing results, we examined the
expression of extracellular matrix proteins and integrin-related
proteins using immunofluorescence and Western blot assays. The 12 T
upward treatment inhibited the expression of LAMB1, collagen I, and
integrin β1 in MLO-Y4 cells. Mechanical homeostasis involves ECM
constituents such as collagens and laminin, which support and transmit
loads. Integrins bridge extracellular and intracellular structures,
while their associated linker proteins (such as talin and vinculin)
connect receptors to the cytoskeleton.[150]^49 The microfilament
skeleton of osteocytes was clustered at the edges of cells treated with
12 T upward, indicative of altered microfilament distribution.
Alternatively, 12 T downward promoted the skeletal arrangement of
osteocytes. Our Western blot results showed that the expression of
β-tubulin and β-actin was less affected by magnetism. However,
vinculin, which is involved in cytochemical signaling in combination
with F-actin, showed opposite expression trends in the 12 T upward and
12 T downward treatment groups.
Wisp2, the most significant DEG between 12 T upward- and 12 T
downward-treated cells, localized to the nucleus, ECM, and
cytoskeleton. Wisp2 was most strongly correlated with the Wnt pathway
based on the STRING protein interactions database. Wisp2 is both a
secretory and cytosolic protein that activates the classical Wnt
pathway and increases β-catenin levels.[151]^50 Herein, we discovered
that the 12 T upward treatment inhibited the Wnt1/LRP6/β-catenin
pathway. In combination with our experimental results, cytoskeleton
stabilizer pretreatment of MLO-Y4 cells attenuated the inhibitory
effect of 12 T upward on the Wnt signaling pathway. Cytoskeleton
inhibitor pretreatment of MLO-Y4 cells inhibited the effect of the 12 T
downward treatment of the Wnt signaling pathway. Thus, cytoskeletal
stability is important for the transduction of the Wnt signaling
pathway in MLO-Y4 cells. Furthermore, the 12 T upward treatment
decreased NO production and increased SOST expression, further
synergistically inhibiting the Wnt pathway in MLO-Y4 cells. Wnt pathway
inhibition further reduced the expression of downstream bone function
protein OPG. NO and OPG are typical cytokines that inhibit osteoclast
differentiation.[152]^47 Alternatively, osteoclast formation was
significantly enhanced following the 12 T upward treatment due to the
significantly lower NO and OPG secreted by cells. Conversely, the 12 T
downward treatment increased NO production and decreased SOST
expression. Higher secretion of NO and OPG suppressed osteoclast
differentiation in the 12 T downward treatment group relative to the
control group.
Overall, the parameters associated with the mechanical stimulation to
which cells were subjected in this study are more standard and
accurate. In MLO-Y4 osteocytes, the ECM-integrin-CSK axis and
Wnt1/LRP6/β-catenin/OPG pathway were altered by magnetic force.
Osteocyte fate and function were altered as a result. We further
clarified the effect of osteocytes on bone reconstruction in response
to different mechanical stimuli. We provide a basis for further
research on this issue in terms of cellular-molecular mechanisms that
are of great importance to clinical practice.
Limitations of the study
This study had some limitations. The first is the short exposure time
of 24 h in LG-HMFs for the cells used for transcriptome sequencing to
ensure that the cells are in optimal condition. Second, only the
differentiation of osteoclasts based on osteocyte secretory factors and
not that based on osteocyte secretory factors was tested for
osteoblastes function. Finally, only the effect of magnetic force on
the expression of ECM-integrin-CSK was examined. The information
transfer between ECM-integrin-CSK is based on previous studies. Further
experiments are needed to verify the transmission of magneto-mechanical
signals in cells.
STAR★Methods
Key resources table
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
__________________________________________________________________
GAPDH Monoclonal antibody Proteintech RRID:[153]AB_210743;
Cat#60004-1-Ig
Anti-Bax antibody Abcam RRID:[154]AB_2938987;
Cat#ab182733
Cleaved Caspase-3 (Asp175) Antibody Cell Signaling Technologies
RRID:[155]AB_2341188;
Cat# 9661
Laminin beta 1 Polyclonal antibody Proteintech RRID:[156]AB_2879288;
Cat#23498-1-AP
Collagen Type I Polyclonal antibody Proteintech RRID:[157]AB_2082037;
Cat#14695-1-AP
Integrin Beta 1 Polyclonal antibody Proteintech RRID:[158]AB_2130085;
Cat#12594-1-AP
β-Actin (13E5) Rabbit mAb Cell Signaling Technologies
RRID:[159]AB_2223172;
Cat#4970
Anti β-Tubulin Mouse Monoclonal Antibody Proteintech
RRID:[160]AB_2881629;
Cat#66240-1-Ig
WNT1 Polyclonal antibody Proteintech RRID:[161]AB_2881013;
Cat#27935-1-AP
LRP6 (C47E12) Rabbit mAb Cell Signaling Technologies
RRID:[162]AB_1950408;
Cat#3395
Beta Catenin Polyclonal antibody Proteintech RRID:[163]AB_2086128;
Cat#51067-2-AP
Anti-Sclerostin antibody Abcam RRID:[164]AB_956321;
Cat#ab63097
Anti-Osteoprotegerin antibody Abcam RRID:[165]AB_2934183;
Cat#ab183910
Cy3-labeled Goat Anti-Rabbit IgG (H + L) Beyotime Biotechnology
RRID:[166]AB_2893015;
Cat#A0516
Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) Abcam RRID:[167]AB_2576208;
Cat#ab150113
HRP-labeled Goat Anti-Rabbit IgG(H + L) Beyotime Biotechnology
RRID:[168]AB_2892644;
Cat#A0208
HRP-labeled Goat Anti-Mouse IgG(H + L) Beyotime Biotechnology
RRID:[169]AB_2860575;
Cat#A0216
__________________________________________________________________
Chemicals, peptides, and recombinant proteins
__________________________________________________________________
Murine sRANK-Ligand Peprotech Cat# 315-11-10UG
Paclitaxel TopScience Cat# T0968
Colchicine TopScience Cat# T0320
__________________________________________________________________
Deposited data
__________________________________________________________________
RNA-seq transcriptome data This paper NCBI-based platforms: NCBI
Sequence Read Archive (SRA): BioProject ID PRJNA932050
__________________________________________________________________
Experimental models: Cell lines
__________________________________________________________________
MLO-Y4 University of Texas Health Science Center RRID:CVCL_M098
RAW 264.7 ATCC RRID:CVCL_0493;
Cat#TIB-71
__________________________________________________________________
Software and algorithms
__________________________________________________________________
GraphPad Prism 8.2.1 [170]https://www.graphpad.com/
Python 3.8 [171]https://www.python.org/
R-project [172]https://www.r-project.org/
ImageJ [173]https://ImageJ.net/software/fiji/downloads
Image-Pro Plus6.0
[174]https://www.epixinc.com/vision_archive/imagepro.htm
__________________________________________________________________
Other
__________________________________________________________________
Collagen Type Ι BD Corning Cat#354236
Crystal Violet Amersco Cat#0528-25G
Triton X-100 Sinopharm Chemical ReagentCo., Ltd Cat#30188928
Cell Counting Kit-8 Beyotime Biotechnology Cat#C0038
Annexin V-FITC Apoptosis Detection Kit Beyotime Biotechnology
Cat#C1062M
ActinRed™ 555 ReadyProbes™ Thermo Fisher Scientific Cat#[175]R37112
DAPI dihydrochloride Beyotime Biotechnology Cat#C1002
NO assay kit Beyotime Biotechnology Cat#S0021S
Leukocyte acid phosphatase (TRAP) Kit Sigma-Aldrich Cat# 387A-1KT
[176]Open in a new tab
Resource availability
Lead contact
Further information and requests for resources should be directed to
and will be fulfilled by the Lead Contact, Peng Shang, Northwestern
Polytechnical University, China ([177]shangpeng@nwpu.edu.cn).
Materials availability
This study did not generate new unique reagents. Further information
and request for resources and reagents should be directed to and will
be fulfilled by the Lead Contact, Peng Shang, Northwestern
Polytechnical University, China ([178]shangpeng@nwpu.edu.cn).
Experiment methods and subject details
Cell lines
The mouse osteocyte-like cell line (MLO-Y4) used in this study was
gifted by Prof. Jean X. Jiang (University of Texas Health Science
Center, San Antonio, TX, USA). MLO-Y4 cells were cultured on
collagen-coated (Collagen Type Ι, BD Corning, Cat#354236) petri dishes.
The cells were cultured in α-MEM medium (Gibco) supplemented with 5%
fetal bovine serum (FBS, Gibco), 5% calf serum (Every Green), 2 mM
L-glutamine, and 1% penicillin/streptomycin (Beyotime Biotechnology,
Cat#C0222) in a humidified 5% CO[2] and 37°C controlled by an incubator
system (Thermo Fisher Scientific).
Pre-osteoclast RAW 264.7 cells were purchased from the Cell Bank of
Chinese Academy of Science (CAS; Shanghai, China), ATCC (TIB-71). RAW
264.7 cells were cultured in α-MEM medium (Gibco) supplemented with 10%
fetal bovine serum (FBS, Gibco), 2 mM L-glutamine, and 1%
penicillin/streptomycin (Beyotime Biotechnology, Cat#C0222). The cells
were cultured in a humidified 5% CO[2] and 37°C controlled incubator
system (Thermo Fisher Scientific).
Method details
Large gradient high magnetic fields exposure system
In this study, LG-HMFs were produced by a superconducting magnet
(JMTA-16T50MF) ([179]Figure 1A). The LG-HMF consisted of the NbTi and
Nb[3]Sn superconductors. To generate the 16 T magnetic field in a
region with a diameter of 50 mm, the superconducting magnet was
combined with reverse and main coils. The main coils consisted of two
NbTi coils and one Nb[3]Sn coil. The main coil was designed to generate
a high field gradient. The reverse coil consisted of a Nb[3]Sn coil
that generates a reverse field for future high magnetic field gradients
of approximately 150 T/m.[180]^27^,[181]^51 In addition to the space
occupied by the temperature control unit in the magnet hole, the
diameter of the space used for the experiment was approximately 44 mm,
while the total length was 400 mm. We independently developed an
experimental platform to study the cell biology effect of
superconducting magnets, including object stages ([182]Figure 1B),
temperature control systems, and gas control systems. The constant
temperature circulation system (MPG-13A, Bluepard instruments) was
composed of a temperature controller, temperature sensor, heater,
circulation pump, and low water lever alarm device. The temperature of
the magnetic chamber was controlled through heat conduction of
temperature-controlled water via the magnet chamber at 37°C–37.5°C. We
designed our original gas mixing device to mix CO[2] and air
proportionally by adjusting the gas flow meters and then humidifying
them through the humidity controller and passing them into the magnet
chamber to ensure the humidity as well as the 5% CO[2] concentration
during cell culture. The direction of the magnetic field inside the
magnet chamber was vertically upward ([183]Figure 1C). In this study,
cells were placed in the positions of 12.56 T, −109 T/m and 12.50 T,
105 T/m.
The object stage ([184]Figure 1B) contained two 12 T cell culture
platforms that were corresponding to different magnetic field gradients
of −109, and 109 T/m in a 5 cm diameter room temperature bore,
respectively. The change in magnetic field strength and gradient within
the LG-HMF exhibited continuity ([185]Figures 1D and 1E). Schematic
diagram of the magnetic and gravity on the cell in the magnet chamber
are illustrated in [186]Figure 1F.
Cell proliferation and viability
For cell colony formation assays, MLO-Y4 cells were seeded in 35 mm
petri dishes at 1000 cells/dish. After 12 h of cell adhesion on the
plates, cells were cultured separately in a geomagnetic incubator, 12 T
upward and 12 T downward LG-HMFs. The medium was refreshed every two
days and colonies were observed after 10 days. Next, cells were washed
with 1×PBS and fixed with 4% paraformaldehyde for 20 min. Subsequently,
1 mL of 0.1% crystal violet staining solution was added to each dish
for 30 min. The excess crystal violet staining solution was washed with
distilled water and air-dried. Finally, we observed the results using
the body vision microscope (SZ61, Olympus) and acquired images using a
DSC-H5 Sony camera.
For cell counting, MLO-Y4 cells were seeded into 35 mm petri dishes at
1 × 10^5 cells/dish. After adherence to the plates, cells were treated
with 12 T upward and 12 T downward LG-HMFs for 24, 48, and 72 h. After
trypsin digestion, we counted the total number of cells using a
hemocytometer.
MLO-Y4 cell viability was measured using a Cell Counting Kit-8
(Beyotime Biotechnology, Cat#C0038). MLO-Y4 cells were inoculated in
removable 96-well plates at a density of 5 × 10^3 cells/dish. After
adherence to the plates, cells were treated with 12 T upward and 12 T
downward LG-HMFs for 24, 48, and 72 h. Next, 10% CCK-8 was added to the
culture medium and incubated for 2 h at 37°C. The absorbance values
were measured at 490 nm using an enzyme marker (Synergy HT, BioTek).
Cell apoptosis assay
MLO-Y4 cell were seeded into 35-mm petri dishes at 1.5 × 10^5
cells/dish. After the MLO-Y4 cells were treated with 12 T upward and
12 T downward LG-HMFs for 24 h, cells were stained using Annexin V-FITC
apoptosis Detection Kit (Beyotime Biotechnology, Cat#C1062M). The cell
culture solution was aspirated into a 2-mL centrifuge tube and the
apoptotic cells were washed once with 1 × PBS; then, an appropriate
amount of trypsin solution was added to digest the cells. The cells
were incubated at room temperature until they could be blown off by a
gentle blow, the collected cell culture medium was added, cells were
gently blown off, transferred to a centrifuge tube, centrifuged at
1000 × g for 5 min, and the supernatant was discarded. The cells were
washed once by gently resuspending in 1 × PBS, centrifugation at
1000 × g for 5 min, and ultimately, the supernatant was discarded.
Next, we added 195 μL Annexin V-FITC conjugate, 5 μL Annexin V-FITC, as
well as 10 μL propidium iodide staining solution and mix gently.
Subsequently, we incubated the solution for 10–20 min at room
temperature (20°C–25°C), protected from light. The detection was
performed using a flow cytometer (FACSCalibur, BD Bioscience). Annexin
V^+/PI^− were considered early apoptotic cells. Annexin V^+/PI^+ were
considered late apoptotic cells.
Cell morphology observation
MLO-Y4 cells were seeded into 35 mm petri dishes at 1 × 10^5
cells/dish. After adhering to the plates, cells were immediately placed
in the LG-HMFs for 24 h. After treatment, cells were washed with
1 × PBS and fixed with 4% paraformaldehyde for 20 min. Next, the fixed
cells were washed with 1 × PBS, stained with 0.1% crystal violet
solution for 30 min, and washed cleanly using ultrapure water. Finally,
light microscopy (MD IL HC, Leica) was used to observe and image the
cells. The cell area and number of dendrites were determined using the
Image-Pro Plus 6.0 software.
Library construction and sequencing
First, total RNA of MLO-Y4 cells was obtained using the MagZol reagent
(Magen, China). The mRNA was enriched using poly-T oligo-attached
magnetic beads. Subsequently, the obtained mRNA was randomly
interrupted in fragmentation buffer, and the first strand of cDNA was
synthesized using the fragmented mRNA as the template. RNaseH was used
to degrade the RNA strand, and the second cDNA strand was synthesized
from dNTPs as raw material under the DNA polymerase I system. The
purified double-stranded cDNA underwent terminal repair, had an A tail
added, and was attached to the sequencing linker. Next, we screened
approximately 370–420 bp of cDNA with AMPureXP beads, amplified the
sequences using PCR, and purified the PCR product again using AMPureXP
beads to finally obtained a library. Fluorescently labeled polymerase
was added to the sequencing flow cell, and the sequencing instrument
passes through to capture the fluorescence signal. Data collection and
statistical analysis were performed using a specific computer software
(Novogene, China).[187]^52^,[188]^53^,[189]^54 ([190]Figure 9).
RNA-seq data processing and function gene annotation
DEGs analysis between the two comparative combinations was performed
using DESeq2 software (1.20.0). DEG analysis of two conditions were
performed using the edgeR software package (3.22.5). p-values were
adjusted using the Benjamini & Hochberg method. After correction,
P-values and log[191]^2 fold change (|log[192]^2 FC|) were used as
broad values for significant differential expression. DEGs were
screened using adjusted P-values <0.05 and |log[193]^2 FC| > 0.5 as
screening criteria. The acquired differentially expressed genes were
imported into Python 3.8, data were read using numpy and pandas, and
then the volcanos were plotted using matplotlib and seaborn. We used
gene set enrichment analysis (GSEA) tools
([194]http://www.broadinstitute.org/gsea/index.jsp) to analyze the GO
and Reactome datasets. GSEA results were plotted using the ggplot2
plotting package in R-project 4.2.2. PPI analysis of DEGs was based on
the STRING database ([195]https://cn.string-db.org/) of known and
predicted protein-protein interactions. The GeneCards database
([196]https://www.genecards.org/) was used to obtain the localization
of genes in cells.
Immunofluorescence staining
MLO-Y4 cells were seeded into confocal petri dishes at a density of
1 × 10^5 cells/dish. After adhering to the plates, cells were placed
under the LG-HMFs for 48 h. The supernatant was removed, and 1× PBS was
used to wash the cells once. Next, cells were fixed with 4%
paraformaldehyde for 20 min and permeabilized with 0.2% Triton X-100
for 5 min (Sinopharm Chemical ReagentCo., Ltd, Cat#30188928).
Subsequently, cells were blocked in 2% BSA (2% BSA-PBS) for 30 min at
room temperature. Next, after 3 washes with 1× PBST, cells were
cultured overnight at 4°C with primary antibodies, including actinRed
555 ReadyProbes Reagent (1:400 dilution in 1× PBS, Thermo Fisher
Scientific, Cat#[197]R37112), mouse anti-β-Tubulin antibody (1:200
dilution in 1× PBS, Proteintech, Cat#66240-1-Ig), rabbit anti-LAMB 1
antibody (1:200 dilution in 1× PBS, Proteintech, Cat#23498-1-AP),
rabbit anti-collagen I antibody (1:200 dilution in 1× PBS, Proteintech,
Cat#14695-1-AP), and rabbit anti-Integrin β1 antibody (1:200 dilution
in 1× PBS, Proteintech, Cat#12594-1-AP). The cells were washed 5 times
with 1× PBS, then stained with Goat anti-Rabbit Alexa
Fluor550-conjugated antibody (1:500 dilution in 1× PBS, Beyotime
Biotechnology, Cat#A0516) and Goat anti-Mouse Alexa Fluor488-conjugated
antibody (1:500 dilution in 1× PBS, Abcam, Cat#ab150113) for 60 min at
room temperature in the dark. Nuclei were stained with DAPI (1:1000
dilution in 1× PBS, Beyotime Biotechnology, Cat#C1002), followed by 5
washing steps. The cells were imaged with using a laser scanning
confocal microscope (SP8, Leica).
Protein expression assay
MLO-Y4 cells were subjected to LG-HMFs for 48 h and washed with 1× PBS.
The RIPA Lysis Buffer (Beyotime Biotechnology, Cat#P0013B) containing
2 mM Protease inhibitor cocktail (Beyotime Biotechnology, Cat#P1005)
and 5 mM Phosphatase inhibitor cocktail (Beyotime Biotechnology,
Cat#P1081) was used to lyse the cells. A commercial BCA Protein Assay
Kit (Beyotime Biotechnology, Cat# P0009) was used to examine the
protein content. Proteins were loaded into the SDS-PAGE gels, separated
through electrophoresis, and then transferred onto a polyvinylidene
fluoride membranes. The polyvinylidene fluoride membranes were blocked
with 5% nonfat-dried milk and then incubated with specific primary
antibodies, including mouse anti-GAPDH (1:5000 dilution in 1× TBST,
Proteintech, Cat#60004-1-Ig), Anti-Bax antibody (1:2000 dilution in 1×
TBST, abcam, Cat# ab182733), Cleaved Caspase-3 (Asp175) Antibody
(1:1000 dilution in 1× TBST, Cell Signaling Technologies, Cat# 9661),
rabbit anti-LAMB 1 antibody (1:1000 dilution in 1× TBST, Proteintech,
Cat#23498-1-AP), rabbit anti-collagen I antibody (1:2000 dilution in 1×
TBST, Proteintech, Cat#14695-1-AP), rabbit anti-Integrin β1 antibody
(1:4000 dilution in 1× TBST, Proteintech, Cat#12594-1-AP), rabbit
anti-β actin antibody (1:1000 dilution in 1× TBST, Cell Signaling
Technologies, Cat#4970), mouse anti-β-Tubulin antibody (1:20000
dilution in 1× TBST, Proteintech, Cat#66240-1-Ig), rabbit anti-Wnt 1
antibody (1:1000 dilution in 1× TBST, Proteintech, Cat#27935-1-AP),
rabbit anti-LRP6 antibody (1:1000 dilution in 1× TBST, Cell Signaling
Technology, Cat#3395), rabbit anti-β catenin antibody (1:1000 dilution
in 1× TBST, Proteintech, Cat#51067-2-AP), rabbit anti-Sclerostin
antibody (1:1000 dilution in 1× TBST, Abcam, Cat#ab63097), and rabbit
anti-Osteoprotegerin antibody (1:1000 dilution in 1× TBST, Abcam,
Cat#ab183910) overnight at 4°C. After washing the membranes five times
with 1× TBST, they were incubated with species-specific secondary
antibody conjugated to horseradish peroxidase (1:2000 dilution in 1×
TBST, Beyotime Biotechnology, Cat#A0208 and Cat#A0216) for 2 h at room
temperature. An ECL Plus Western Blotting Detection System (JS-M6P, P&Q
Science Technology) was used to image the immunoreactive bands. The
grayscale bands were determined using the ImageJ 1.8.0 software.
Detection of osteoclast differentiation
MLO-Y4 cells were collected in the medium treated with control, 12 T
upward, and 12 T downward LG-HMFs for 48 h. The medium was filtered
through a 0.22-μm membrane to remove bacteria and mixed with α-MEM
containing 10% fetal bovine serum at a ratio of 1:2 to obtain
conditioned medium (CM). To induce osteoclast differentiation, Raw264.7
cells were cultured in α-MEM containing 10% fetal bovine serum and
50 ng/mL soluble RANKL as previously described.[198]^55 After 24 h, the
medium was replaced with fresh CM. This procedure was repeated every
day.
For F-actin rings staining, until day 4, cells were stained with
actinRed 555 ReadyProbes Reagent (1:400 dilution in 1× PBS, Thermo
Fisher Scientific, Cat#[199]R37112) and DAPI (1:1000 dilution in 1×
PBS, Beyotime Biotechnology, Cat#C1002). The procedure was similar to
that of immunofluorescence staining. The osteoclast F-actin rings were
observed and imaged using an inverted fluorescence microscope (Observer
3, ZEISS).
For tartrate-resistant acid phosphate (TRAP) staining, on day 4, cells
were washed with 1× PBS and fixed with 4% paraformaldehyde for 20 min.
Next, cells were stained with Leukocyte Acid Phosphatase Kit
(Sigma-Aldrich, Cat#387A-1KT) according to the manufacturer’s protocol.
The results were observed and imaged using a light microscope (CKX53,
Olympus). The cells with a burgundy color or more than three nuclei
were recognized as osteoclasts. The number or area of formed
osteoclasts was calculated using the Image-Pro Plus 6.0 software.
Bioassay for NO production
MLO-Y4 cell were seeded into 35 mm petri dishes at 1.5 × 10^5
cells/dish. After the treatment with LG-HMFs for 48 h, the MLO-Y4 cells
supernatant was collected. First, we diluted the standard with the
solution used for the sample to be tested and made a standard curve
according to manufacturer’s protocol (Beyotime Biotechnology,
Cat#S0021S). We added standards and samples in 96-well plates at a
volume of 50 μL/well. Next we added Griess Reagent I to each well
(50 μL/well) followed by Griess Reagent II (50 μL/well). The absorbance
values were measured at 540 nm using an enzyme marker (Synergy HT,
BioTek).
Quantification and statistical analysis
All experimental data are expressed as mean ± SD, and statistical
analysis was performed using GraphPad Prism version 8.2.1 software for
Windows (GraphPad Software, San Diego, California USA). Data obtained
from western blots are representative for 3 independent experiments.
One-way ANOVA with Tukey’s multiple-comparison method was used to
evaluate the differences between the control, 12 T upward, and 12 T
downward. P-values <0.05 were considered statistically significant.
Significance was defined as follows: ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Differential expression analysis was
compared between the two combinations using DESeq2 1.20.0 software. The
method of Benjamini and Hochberg was used to adjust the resulting
P-values to control for false discovery rates (FDRs). Genes with an
FDR-corrected P-value <0.05 by DESeq2 were considered differentially
expressed. Significance for GO and Reactome enrichment analysis was
determined using an FDR-corrected P-value (<0.05).
Acknowledgments